Brief: Inovio Reports First Quarter 2023 Financial Results And Operational Highlights
10/05/2023 21:18
May 10 (Reuters) - Inovio Pharmaceuticals Inc INO.O :
* INOVIO REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS AND
OPERATIONAL HIGHLIGHTS
* INOVIO PHARMACEUTICALS INC - COMPANY MAINTAINS CASH RUNWAY
PROJECTION INTO Q1 2025
* INOVIO PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.16
Source text for Eikon: ID:nPn3w3j1La
Further company coverage: INO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inovio Pharmaceuticals
See all newsBrief: Inovio Announces Favorable Judgment In Litigation With Vgxi, Inc. And Geneone Life Science
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Inovio Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Inovio Q2 net loss narrows on warrant gain, lower costs
Brief: Inovio Pharmaceuticals Q2 Operating Expenses USD 18.6 Million